article thumbnail

Drug developers look at innovative mechanisms to tackle dry eye syndrome

Pharmaceutical Technology

Dry eye syndrome (DES) is an indication whose mainstay treatment has been dominated by Allergan’s Restasis (cyclosporine ophthalmic emulsion 0.05%) ever since its launch in 2003 in the US. Current treatment options for DES are dominated by a mix of prescription and over-the-counter (OTC) products.

article thumbnail

The Inflation Reduction Act Passed, Now What?

PM360

In April 2022, we released an article describing proposed policies from the federal government that could impact prescription drug pricing. The facts: All Part D beneficiaries will pay $0 out of pocket for prescriptions in the catastrophic phase. On August 16, 2022, President Biden signed the Inflation Reduction Act (IRA) into law.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Primer on Telepharmacy

Nixon Gwilt Law

Due to the success of the North Dakota Telepharmacy Project, the Board of Pharmacy in North Dakota permanently implemented telepharmacy regulations in 2003. E-prescribing is the practice of electronically sending a prescription directly to a pharmacy from the point-of-care. What is Telepharmacy? How Does Telepharmacy Work in Practice?

Medical 52
article thumbnail

Beating the Big C

Pharmaceutical Technology

” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” “And there’s a tremendous opportunity to meet their needs.”

article thumbnail

AbbVie Exploits Offshore Subsidiaries to Avoid Paying Taxes

World of DTC Marketing

prescription drug sales signals that big pharma will do anything to avoid hurting profits. For several years, Humira was the best-selling prescription drug in the world.1 Since AbbVie began to sell Humira in 2003, the price of Humira has been raised 27 times.

Sales 269
article thumbnail

Trump’s lie on drug prices

World of DTC Marketing

In 2003 President George W. According to the federal Centers for Medicaid and Medicare Services, our federal government spent $298 billion on prescription drugs at that time. It was a bizarre and fact-free claim, typical of Trumpian hyperbole.